| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.052 | 0.3 |